Navigation Links
CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
Date:10/24/2007

h Stage III or Stage IV malignant melanoma.

"We are encouraged by these initial clinical results on CR011-vcMMAE and the suggestion of potential anti-cancer activity in patients with previously progressive disease, which support continued evaluation of this antibody-drug conjugate in the treatment of advanced melanoma. We continue to enroll patients into the trial, and look forward to further characterizing the activity of this novel therapeutic," commented Dr. Mario Sznol, co-Principal Investigator, Co-Director of the Melanoma Program at the Yale Cancer Center in New Haven, CT.

This open-label, dose-escalation study conducted at the Yale Cancer Center, New Haven, CT, MD Anderson Cancer Center, Houston, TX, and The Angeles Clinic and Research Institute, Santa Monica, CA, is evaluating the safety, tolerability and pharmacokinetics of CR011-vcMMAE for patients with unresectable Stage III or Stage IV melanoma who have failed no more than one prior line of cytotoxic therapy. The first part of the trial will evaluate cohorts of patients receiving increasing doses of CR011-vcMMAE to determine the MTD. After determination of the MTD, up to approximately 32 additional patients will be enrolled and treated at the MTD to further define the safety and efficacy of CR011-vcMMAE.

CuraGen will host a conference call on Thursday, October 25, 2007 at 5:00 p.m. Eastern time to discuss these Phase I results on CR011-vcMMAE and the four posters discussing Phase I and Phase II clinical trial results with belinostat being presented at the AACR-NCI-EORTC International Conference.

Conference Call Details and Dial-in Information

Date: Thursday, October 25, 2007

Time: 5:00 p.m. Eastern time

Dial-in: 877-272-5391 (domestic)

706-758-4315 (international)

Passcode: 21928842

Webcast: Access to the live webcast and presentation are available at


SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CuraGen Presents Update on Clinical Development Program for Belinostat
2. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
3. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 Reportlinker.com announces that ... its catalogue: Global Orthopedic Soft Tissue ... http://www.reportlinker.com/p02316671/Global-Orthopedic-Soft-Tissue-Repair-Devices-Market-2014-2018.html About Orthopedic Soft ... mass of cells that connect, support, or surround ... tissues such as tendons, ligaments, cartilage, fascia, and ...
(Date:8/27/2014)... Aug. 27, 2014  Decision Resources Group finds ... oncology, hematology-oncology, rheumatology, gastroenterology, endocrinology and nephrology) expect ... a biosimilar has been assessed in to be ... choose to prescribe. Other key ... Acceptance of Biosimilars Across Physician Specialties ...
(Date:8/27/2014)... , Aug. 27, 2014 Decision Resources Group ... the Memphis health system and ... clinical integration, with rivals Methodist Le Bonheur Healthcare and ... groups to coordinate patient care. In addition, a national ... the most health plan enrollment in the ...
Breaking Medicine Technology:Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2Memphis-area Health Systems Turn Attention to Clinical Integration 2
... Must for Clinical Trials Management, WASHINGTON, ... Centers (AAHC) today launched a new Clinical ... center leaders,research administrators, and chief compliance officers ... for the,research enterprise, particularly to manage and ...
... and limited launch in Italy continue, FRANKLIN, Mass., ... announced today that it will defer the commencement of ... prevention of,Contrast-Induced Nephropathy (CIN). The company continues to support ... well,as the limited market launch of RenalGuard in Europe, ...
Cached Medicine Technology:New AAHC Toolkit Available to Optimize Clinical Research Administration 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 3PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 4PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 5
(Date:8/27/2014)... 27, 2014 Today, Zane Benefits, the ... compliance tips for administering a premium reimbursement plan. ... full effect, compliance is top of mind for employers, ... individual health insurance and premium reimbursement, there are important ... the 35 minute webinar, Zane Benefits President, Rick Lindquist, ...
(Date:8/27/2014)... Recently, iFitDress.com, a professional company of women’s ... of romantic bridal gowns . To top it ... (up to 66 percent off) when buying the company’s ... has been updated with these new items. All its ... that all clients can gain an enjoyable shopping experience ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 New Jersey’s ... at The Ridgewood County Club during The Barclays – ... in each of the tournament’s four rounds, stepped his ... Horizon Blue Cross Blue Shield of New Jersey (Horizon ... Hoffmann, a Wyckoff native playing before family and friends ...
(Date:8/27/2014)... Young adults who struggled with depression in adolescence appear ... reporting. The findings might improve understanding of depression ... and treat the illness, according to the University of ... scans on 30 volunteers, ages 18 to 23, who ... group of 23 young adults who never had depression. ...
(Date:8/27/2014)... August 27, 2014 Michigan Head & Neck ... children of a local elementary school by ensuring they have ... School has year-round attendance, and Michigan Head & Neck Institute ... the new school year. , "There are a lot of ... a great way to give back to our community," said ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Announces Upcoming Webinar on Compliance 2Health News:Promotion For Romantic Bridal Gowns Launched By Professional Company iFitDress.com 2Health News:Morgan Hoffmann, PGA TOUR Pro & Wyckoff Native, golfs and walks his way to top 10 finish at The Barclays while raising additional $7,500 for charity 2Health News:Study: Young Adults Who Had Depression Have 'Hyper-Connected' Brain Networks 2Health News:Michigan Head & Neck Institute is Conducting Their 2nd Annual School Supplies Drive at Their Facility to Benefit Local Year-Round Elementary School Students 2
... people, animals, and our environment has created a new ... inextricably and globally interconnected, without borders. It is against ... multidisciplinary effort to attain optimal health of humans, animals ... a session at the annual meeting of the American ...
... becomes more common. Swedish scientist Laura Fratiglioni has shown that ... Factors from blood pressure and weight to the degree of ... gets older. The lengthening of the average life span ... of aging related disorders, one of which is cognitive impairment ...
... researchers generally credit the desire for smaller families for the ... suggests that prevention of unwanted births may actually be a ... birth control means that people have better control of when ... the Initiative in Population Research at Ohio State University. ...
... This release is available in French . ... continues to spread in cities around the world. Vanier Canada ... between cities, water and health at the THINK CANADA Press ... (AAAS) conference Sunday. Mulligan is a PhD student at ...
... more time to conduct in overweight and obese patients ... at Hospital for Special Surgery in New York. The ... Orthopaedic Surgeons annual meeting, held Feb. 15-19 in San ... scheduling surgeries, operating room utilization and personnel staffing, and ...
... developed an optical technology that provides unprecedented images under ... to detect and examine skin lesions to determine whether ... the suspected tumor out of the skin and analyze ... roughly one-foot-long cylindrical probe is placed in contact with ...
Cached Medicine News:Health News:One Health: From ideas to implementation, rhetoric to reality 2Health News:One Health: From ideas to implementation, rhetoric to reality 3Health News:One Health: From ideas to implementation, rhetoric to reality 4Health News:Look after your brain 2Health News:Family planning programs have success in developing countries, but need to be expanded 2Health News:Family planning programs have success in developing countries, but need to be expanded 3Health News:Is the link between poverty and water-related disease making rich people sick? 2Health News:Knee replacement surgeries take more time, are more costly in overweight individuals 2Health News:Knee replacement surgeries take more time, are more costly in overweight individuals 3Health News:A new high-resolution method for imaging below the skin using a liquid lens 2
Enzyme Immunoassay of Tissue Plasminogen Activator Antigen by ELISA Method, 96 tests....
Citrated human plasma for the calibration of vWF assays by the immuno-turbidimetric method on STA© analyzers.(STA© Liatest© vWF #0518)....
Heparin-Platelet Factor 4 Induced Antibody...
Control Plasma for Assays of Low MolecularWeight Heparins (LMWH) using Anti-Xa Method on STA© Analyzers....
Medicine Products: